Skip to main content
. 2021 May 14;11(5):633. doi: 10.3390/brainsci11050633

Table 1.

Baseline patient characteristics.

Survivors Non-Survivors p-Value
number of patients 59 43
median age (IQR, yrs) 63 (53–72) 68 (59–81) p = 0.03
female sex 21 (36%) 16 (37%) p = 1.0
ICH score ≥ 3 at admission 4 (7%) 16 (37%) p < 0.0001
initial GCS ≤ 12 28 (48%) 36 (84%) p < 0.0001
ICH volume ≥ 30 mL 24 (41%) 29 (67%) p = 0.009
known diabetes mellitus prior ictus 5 (9%) 7 (16%) p = 0.4
anticoagulant medication prior ictus
antiplatelet medication
combination
8 (14%)
15 (25%)
1 (2%)
6 (14%)
13 (30%)
0 (0%)
p = 1.0
initial SBP (mmHg)
mild (<180)
moderate (180–219)
severe (≥220)
36 (61%) 27 (63%)
17 (29%) 10 (23%) p = 0.7
6 (10%) 6 (14%)
median admission lactate (IQR, mmol/L) 1.48 (1.05–1.88) 1.88 (1.49–2.41) p = 0.004
median admission glucose (IQR, mg/dL) 126 (112–132) 143 (120–183) p = 0.001

IQR, interquartile range; yrs, years; ICH, intracerebral hemorrhage; GCS, Glasgow Coma Scale; SBP, systolic blood pressure.